A promoting early presentation intervention increases breast cancer awareness in older women after 2 years: a randomised controlled trial by Forbes, L J L et al.
A promoting early presentation intervention increases breast
cancer awareness in older women after 2 years: a randomised
controlled trial
LJL Forbes*,1, L Linsell
1, L Atkins
1, C Burgess
1, L Tucker
1, L Omar
1 and AJ Ramirez
1
1Promoting Early Presentation Group, Kings College London, Adamson Centre for Mental Health, South Wing, St Thomas’ Hospital, London SE1 7EH, UK
BACKGROUND: We have developed the Promoting Early Presentation (PEP) Intervention to equip older women with the knowledge,
skills, confidence and motivation to present promptly with breast symptoms, and thereby improve survival from breast cancer.
The PEP Intervention consists of a 10-min interaction between a radiographer and an older woman, supported by a booklet.
Our previous report showed that at 1 year, the PEP intervention increased the proportion who were breast cancer aware compared
with usual care.
METHODS: We randomised 867 women aged 67–70 years attending for their final routine appointment on the National Health
Service Breast Screening Programme to receive the PEP Intervention, a booklet alone or usual care. The primary outcome was breast
cancer awareness measured using a validated questionnaire asking about knowledge of breast cancer symptoms, knowledge that the
risk of breast cancer increases with age and breast checking behaviour.
RESULTS: At 2 years, the PEP Intervention increased the proportion who were breast cancer aware compared with usual care
(21 vs 6%; odds ratio 8.1, 95% confidence interval 2.7–25.0).
CONCLUSIONS: The uniquely large and sustained effect of the PEP Intervention on breast cancer awareness increases the likelihood
that a woman will present promptly should she develop breast cancer symptoms up to many years later.
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Delay in diagnosis leads to poorer survival in breast cancer
(Richards et al, 1999). Delay in diagnosis may be due to delayed
presentation by some women or delayed onward referral by
primary care physicians. Older women are more likely to delay
presentation in breast cancer (Ramirez et al, 1999), present with
more advanced disease, and have much higher short-term
mortality rates than younger women (Moller et al, 2010). Delay
in presentation is likely to be due to poor awareness of symptoms
and negative beliefs about breast cancer and its treatment
(Ramirez et al, 1999; Grunfeld et al, 2002).
Promoting early presentation in women attending for their final
round of breast screening, at whatever age that may be, may reduce
stage at diagnosis cost-effectively among older women. It is
unlikely to lead to overdiagnosis: a very high proportion of older
women referred to symptomatic breast clinics are subsequently
diagnosed with breast cancer (Wishart et al, 2010).
We have developed an intervention to equip older women with
breast cancer awareness (Burgess et al, 2008), in other words, the
knowledge, confidence, motivation and skills to present promptly
to primary care on discovering breast cancer symptoms, and
thereby improve survival. We have carried out a randomised
controlled trial of this intervention delivered when women
attended for final routine mammogram at age 67–70 years on
the UK National Health Service Breast Screening Programme. At 1
year, the intervention increased the proportion of women who
were breast cancer aware more than any other intervention of its
kind (Austoker et al, 2009; Linsell et al, 2009). Continued follow-up
is important because a woman needs to retain the knowledge,
confidence, motivation and skills to present promptly; it may be
many years before she develops a breast symptom that may be due
to breast cancer. We report here the 2-year results of the trial. The
intervention is now known as the Promoting Early Presentation
(PEP) Intervention.
MATERIAL AND METHODS
The PEP Intervention is a scripted 10-min one-to-one interaction
between a radiographer and the woman, supported by a booklet,
delivered after the woman has had her mammographic examina-
tion. The script covers the symptoms of breast cancer, the
increased risk of developing breast cancer with increasing age,
rehearsal of the skills required to check for breast changes and
what women should do if they discover a breast change.
We randomised women attending their final routine appoint-
ment on the National Health Service Breast Screening Programme
to the PEP Intervention, or booklet alone, or usual care, in three
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sbreast screening services in London and South East England
during 2007–2008. Usual care consisted of standard practice in the
National Health Service Breast Screening Programme after final
invited mammogram, in other words, brief verbal and/or written
information to each woman that she would not longer be invited
for screening every 3 years, but that she might continue to be
screened at this interval on request.
The primary outcome was breast cancer awareness measured
using a self-complete postal questionnaire (Linsell et al, 2010)
asking about knowledge that the risk of breast cancer increases
with age (‘In the next year who is most likely to get breast cancer?’
A 30-year-old woman; a 50-year-old woman; a 70-year-old woman;
a woman of any age), recognition of non-lump symptoms of breast
cancer from a list and reported frequency of breast checking (‘How
often do you check your breasts?’ Rarely or never; at least every 6
months; at least once a month; at least once a week.).
We measured breast cancer awareness at baseline, 1 month,
6 months, 1 year and 2 years post randomisation. We analysed the
data using robust generalized estimating equations with a logit link
and binomial distribution for the outcome (Zeger and Liang, 1986)
using Stata version 11 (StataCorp, College Station, TX, USA). This
method takes account of the correlation between repeated
observations of the same individual. We performed an unadjusted
analysis and repeated it adjusting for baseline characteristics:
marital status, education, ethnicity and Index of Multiple
Deprivation.
Our previous report provides further detail of the methods
(Linsell et al, 2009).
RESULTS
We randomised 867 women to receive usual care (n¼287), the
booklet alone (n¼294) or the PEP Intervention (n¼286; Figure 1).
We received breast cancer awareness questionnaires from 78% at
2 years; response rates were similar in each arm (Figure 1).
Fifty-one women (6%) were lost to follow-up.
Women who responded at 2 years were more likely to be
married or cohabiting and to be of white British ethnic group,
and lived in less deprived areas than women who did not
respond (Table 1). There was no conclusive evidence that women
who responded at 2 years had better breast cancer awareness at
baseline. The differences between responders and non-responders
for the three components of breast cancer awareness were incon-
sistent and of borderline significance.
Table 2 shows breast cancer awareness and its components at
baseline and 2 years in the three arms of the trial. Figure 2 shows
the change in breast cancer awareness score and its components
at baseline, 1 month, 6 months, 1 year and 2 years. The PEP
Intervention increased the proportions who were breast cancer
aware at 2 years compared with usual care, and the booklet alone
did not. Knowledge of non-lump symptoms, knowledge that the
risk of breast cancer increased with age and reported breast
checking increased in the PEP Intervention and booklet arms over
follow-up. However, knowledge of non-lump symptoms and
reported breast checking, but not knowledge of age-related risk,
also increased in the usual care arm.
In the analysis adjusting for baseline characteristics, the
odds ratios (ORs) for breast cancer awareness for the booklet vs
usual care and the PEP Intervention vs usual care were larger
(booklet vs usual care: OR 2.8, 95% confidence interval (CI)
342 (28%) excluded
176 chose not to participate
  70 insufficient English
  48 missed for logistic reasons
  28 significant medical disorder
  20 going overseas        
1945 approached
1209 (62%) assessed
for eligibility
867 (72%)
randomly allocated
PEP INTERVENTION
286 (33%) allocated
279 received allocated
intervention
USUAL CARE
287 (33%) allocated
286 received allocated
intervention
BOOKLET ALONE
294 (34%) allocated
291 received allocated
intervention
Questionnaire
completed at
Baseline: n=287
2 years: n=230 (80%)
Lost to follow-up†: n=13 (5%)
Questionnaire
completed at
Baseline: n=292
2 years: n=230 (78%)
Lost to follow-up†: n=18 (6%)
Questionnaire
completed at
Baseline: n=284
2 years: n=216 (76%)
Lost to follow-up†: n=20 (7%)
Figure 1 Flow of participants through trial.
wLost to follow-up: withdrew
from the trial, died or moved away without giving forwarding address.
Table 1 Comparison of baseline characteristics of responders and non-
responders at 2 years
Responded
at 2 years
(n¼676)
No response
at 2 years
(n¼187)
P
value*
Marital status
Married or cohabiting 401 (60%) 86 (47%) 0.001
Educational level
No formal qualifications 240 (38%) 78 (46%) 0.15
O level or equivalent 196 (31%) 51 (30%)
A level or equivalent 81 (13%) 13 (8%)
Degree or above 111 (18%) 28 (16%)
Ethnic group
White British 479 (72%) 90 (49%) o0.001
White other 57 (9%) 21 (12%)
Black Caribbean 70 (11%) 41 (23%)
Other 57 (9%) 30 (16%)
Index of Multiple Deprivation
Median interquartile range; 0 (least)
to 100 (most) deprived
16.5
(7.8–28.1)
22.4
(14.6–33.0)
o0.001
Baseline breast cancer awareness
Identified five or more
non-lump symptoms AND
16/643
(2%)
6/171
(4%)
0.53
identified a 70-year-old
woman as most likely
to get breast cancer AND
reported breast checking
at least once a month
Baseline knowledge of breast cancer symptoms
Identified five or more
non-lump symptoms
293/667
(44%)
66/183
(36%)
0.06
Baseline knowledge that risk increases with age
Identified a 70-year-old
woman as most likely
to get breast cancer
67/653
(10%)
27/174
(16%)
0.05
Baseline reported breast checking
Reported breast checking
at least once a month
362/672
(54%)
83/185
(45%)
0.03
*P values from Pearson’s w
2 test for categorical variables and the Wilcoxon rank sum
test for Index of Multiple Deprivation.
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s0.9–9.1; PEP Intervention vs usual care: OR 12.2, 95% CI 3.8–38)
than for the unadjusted results. The CIs were, however, much wider.
DISCUSSION
The PEP Intervention increased breast cancer awareness in older
women compared with usual care at 2 years: 21% of the women
who received the PEP Intervention were breast cancer aware
compared with 6% of women who received usual care. Of the three
components of breast cancer awareness the PEP Intervention had
the most marked effect compared with usual care on knowledge
that the risk of breast cancer increases with age.
The size of the effect of the PEP Intervention fell slightly between
1 and 2 years compared with usual care. This may be at least partly
due to the increase in breast cancer awareness in the usual care
Table 2 Breast cancer awareness at baseline and 2 years post-randomisation
Baseline Two years
Usual care Booklet PEP Intervention Usual care Booklet PEP Intervention
Breast cancer awareness
Number (%) breast cancer aware
a 9/267 8/275 5/272 13/218 19/217 42/202
(3.4) (2.9) (1.8) (6.0) (8.8) (20.8)
Odds ratio
b (95% CI), P value (vs usual care) 1.0 1.8 (0.6–5.3), 0.32 8.1 (2.7–25.0), o0.001
Knowledge of breast cancer symptoms
Identified five or more non-lump symptoms (%) 111/284 126/286 122/280 140/223 153/226 156/211
(39.1) (44.1) (43.6) (62.8) (67.7) (73.9)
Odds ratio
b (95% CI), P value (vs usual care) 1.0 1.1 (0.7–1.6), 0.66 1.4 (0.9–2.1), 0.11
Knowledge that risk increases with age
Identified a 70-year-old woman as most likely
to get breast cancer (%)
30/269 36/282 28/276 19/224 36/223 60/207
(11.2) (12.8) (10.1) (8.5) (16.1) (29.0)
Odds ratio
b (95% CI), P value (vs usual care) 1.0 1.8 (0.9–3.5), 0.08 4.8 (2.6–9.0), o0.001
Breast checking
Reported breast checking at least once a month (%) 152/285 139/288 154/284 157/229 152/228 164/216
(53.3) (48.3) (54.2) (68.6) (66.7) (75.9)
Odds ratio
b (95% CI), P value (vs usual care) 1.0 1.1 (0.8–1.6), 0.54 1.3 (0.9–1.9), 0.14
Abbreviation: CI¼confidence interval.
aA woman was considered breast cancer aware if she: identified at least five non-lump symptoms; identified that a 70-year-old woman is
most at risk of breast cancer (rather than a 30-year-old, a 50-year-old or a woman of any age); and reported checking her breasts at least once a month.
bCrude odds ratios – not
adjusted for baseline characteristics.
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Figure 2 Breast cancer awareness and component items over follow-up.
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questionnaire itself increased breast cancer awareness (a recog-
nised phenomenon known as the ‘mere measurement’ effect; Godin
et al, 2008) in the usual care arms more than the intervention arms.
Also, media reports or cancer awareness initiatives may have increased
breast cancer awareness in the usual care arm. Another possible
explanation is differential response between the three arms; women
in the usual care arm who returned questionnaires at 2 years were
slightly better educated than their counterparts in the booklet or
PEP Intervention arms (data not shown).
We have found no published reports of randomised controlled
trials of interventions to promote cancer awareness and early
presentation that have followed-up the participants for as long as
2 years. None of the trials of similar interventions included in a
systematic review followed up the participants for more than 1 year
after the final component of the intervention; all found much more
modest effects on cancer awareness (Austoker et al, 2009).
Prolonged follow-up in trials of interventions of this kind is
important because their purpose is not simply to raise cancer
awareness for its own sake but to provide people with the
knowledge, motivation, confidence and skills to detect and
interpret symptoms appropriately and present promptly to
primary care. They need to have a sustained effect, because even
in older women, it may be many years before symptoms develop.
Strengths of our trial include the high level of participation and
the prolonged length of follow-up, combined with a high response
to follow-up. We used a validated instrument for measuring breast
cancer awareness (Linsell et al, 2010).
Now that the PEP Intervention has been shown to increase
breast cancer awareness in women attending their final round of
breast screening, we plan studies to identify and test models of
delivery in women who do not attend and who may be at highest
risk of delayed symptomatic presentation.
The PEP Intervention, a 10-min interaction with a health
professional plus a booklet, promotes breast cancer awareness
in older women more, and for longer, than any other intervention
of its kind. The English National Health Service Breast Screening
Programme is currently piloting implementation of the PEP
Intervention in a number of breast screening services to examine
feasibility and costs, and the effect on breast cancer awareness in
routine clinical practice. If piloting is successful and it is
implemented across the Breast Screening Programme, we can
examine whether the gains in breast cancer awareness translate
into a reduction in the incidence of advanced cancers (and deaths)
from older women no longer covered by the programme.
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